Re: 8 weeks into ZEN-3694 trial today

No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 8 weeks into ZEN-3694 trial today

in response to

Re: 8 weeks into ZEN-3694 trial today

fouremm

posted on Aug 10, 2016 10:52PM

If I recall correctly, Don mentioned in January that by the third or fourth dose level that they may start to see some efficacy. But they will keep increasing the dose until they find the maximally tolerated dose, which will help them determine the dose that elicits maximal efficacy with minimal adverse events for future studies.